In ₹ Crore except Per Share 12 Months Ending | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|
| Revenue from Operations | 484.6 | 986.4 | 563.2 | 728.6 | 608.9 | |
| Other Income | 0.6 | 1.8 | 1.7 | 0.7 | 1.0 | |
| Total Income | 485.2 | 988.2 | 564.8 | 729.4 | 609.9 | |
| Expenses | ||||||
| + Cost of Materials Consumed | 6.6 | 10.0 | 8.1 | 2.1 | 5.0 | |
| + Purchases of Stock-in-Trade | 400.9 | 899.8 | 539.0 | 588.9 | 643.3 | |
| + Changes in Inventories | 24.9 | -27.7 | -38.6 | 78.3 | -95.8 | |
| + Employee Benefit Expense | 3.7 | 8.8 | 6.5 | 9.4 | 6.2 | |
| + Finance Costs | 7.8 | 17.4 | 6.4 | 6.2 | 5.9 | |
| + Depreciation & Amortisation | 1.5 | 3.1 | 1.7 | 1.6 | 1.7 | |
| + Other Expenses | 29.3 | 56.3 | 26.5 | 28.8 | 29.5 | |
| Total Expenses | 474.7 | 967.7 | 549.5 | 715.3 | 595.8 | |
| EBITDA | 19.2 | 39.2 | 21.8 | 21.1 | 20.7 | |
| EBIT | 17.7 | 36.1 | 20.1 | 19.6 | 19.0 | |
| Profit | ||||||
| PBT before Exceptional Items | 10.5 | 20.5 | 15.3 | 14.1 | 14.1 | |
| Pretax Income | 10.5 | 20.5 | 15.3 | 14.1 | 14.1 | |
| + Current Tax | 3.1 | 6.2 | 2.9 | 2.4 | 3.7 | |
| + Deferred Tax | -0.6 | -0.8 | 1.0 | 0.8 | -0.1 | |
| Tax Expense | 2.5 | 5.4 | 3.8 | 3.2 | 3.6 | |
| Net Income | 8.0 | 15.1 | 11.5 | 10.8 | 10.6 | |
| + Net Income — Continuing Ops | 8.0 | 15.1 | 11.5 | 10.8 | 10.6 | |
| + Other Comprehensive Income | -0.1 | 0.4 | -0.1 | 0.3 | -0.3 | |
| Total Comprehensive Income | 7.9 | 15.5 | 11.4 | 11.1 | 10.3 | |
| Per Share | ||||||
| Basic EPS | 1.27 | 1.75 | 1.61 | 1.25 | 1.22 | |
| Diluted EPS | 1.27 | 1.75 | 1.61 | 1.25 | 1.22 | |
| Other Comprehensive Income — detail | ||||||
| + Other Comprehensive Income | -0.1 | 0.4 | -0.1 | 0.3 | -0.3 | |
| + Items NOT to be Reclassified to P&L | -0.1 | 0.5 | -0.1 | 0.4 | -0.3 | |
| + Tax on Items NOT to be Reclassified | -0.0 | 0.1 | -0.0 | 0.1 | 0.0 | |
| Per Share — as-filed variants | ||||||
| Basic EPS — Continuing Operations | 1.27 | 1.75 | 1.61 | 1.25 | 1.22 | |
| Diluted EPS — Continuing Operations | 1.27 | 1.75 | 1.61 | 1.25 | 1.22 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||||
| Related-party Transactions — During the Period | — | 29.9 | — | 26.4 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | ||||||
| Gross Profit | 52.2 | 104.3 | 54.8 | 59.3 | 56.3 | |
| Gross Margin % | 10.78 | 10.58 | 9.72 | 8.14 | 9.25 | |
| Adjusted (ex-Exceptional Items) — derived | ||||||
| Pretax Income (Adjusted, as filed) | 10.5 | 20.5 | 15.3 | 14.1 | 14.1 | |
| Net Income Adj (tax-effected) | 8.0 | 15.1 | 11.5 | 10.8 | 10.6 | |
| EPS Adj | 1.27 | 1.75 | 1.61 | 1.25 | 1.22 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | 63.3 | 86.7 | 86.7 | 86.7 | 86.7 | |